Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $1.47 billion. The enterprise value is $2.84 billion.
Important Dates
The next confirmed earnings date is Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 36.46 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 36.46M |
| Shares Outstanding | 36.46M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 101.84% |
| Float | 36.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.88 |
| PS Ratio | 1.09 |
| Forward PS | 1.08 |
| PB Ratio | 6.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.49 |
| P/OCF Ratio | 8.87 |
| PEG Ratio | 0.76 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.39, with an EV/FCF ratio of 29.90.
| EV / Earnings | n/a |
| EV / Sales | 2.11 |
| EV / EBITDA | 7.39 |
| EV / EBIT | 10.02 |
| EV / FCF | 29.90 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 6.15.
| Current Ratio | 2.00 |
| Quick Ratio | 0.92 |
| Debt / Equity | 6.15 |
| Debt / EBITDA | 3.55 |
| Debt / FCF | 15.17 |
| Interest Coverage | 2.98 |
Financial Efficiency
Return on equity (ROE) is -88.14% and return on invested capital (ROIC) is 9.33%.
| Return on Equity (ROE) | -88.14% |
| Return on Assets (ROA) | 7.67% |
| Return on Invested Capital (ROIC) | 9.33% |
| Return on Capital Employed (ROCE) | 15.84% |
| Revenue Per Employee | $843,938 |
| Profits Per Employee | -$221,125 |
| Employee Count | 1,600 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.07 |
Taxes
| Income Tax | -83.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.96% in the last 52 weeks. The beta is 1.39, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -11.96% |
| 50-Day Moving Average | 43.80 |
| 200-Day Moving Average | 42.22 |
| Relative Strength Index (RSI) | 31.23 |
| Average Volume (20 Days) | 205,165 |
Short Selling Information
The latest short interest is 1.21 million, so 3.32% of the outstanding shares have been sold short.
| Short Interest | 1.21M |
| Short Previous Month | 1.23M |
| Short % of Shares Out | 3.32% |
| Short % of Float | 3.35% |
| Short Ratio (days to cover) | 5.78 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.35 billion and -$353.80 million in losses. Loss per share was -$9.74.
| Revenue | 1.35B |
| Gross Profit | 474.70M |
| Operating Income | 283.70M |
| Pretax Income | -528.40M |
| Net Income | -353.80M |
| EBITDA | 384.90M |
| EBIT | 283.70M |
| Loss Per Share | -$9.74 |
Full Income StatementBalance Sheet
The company has $71.50 million in cash and $1.44 billion in debt, giving a net cash position of -$1.37 billion or -$37.59 per share.
| Cash & Cash Equivalents | 71.50M |
| Total Debt | 1.44B |
| Net Cash | -1.37B |
| Net Cash Per Share | -$37.59 |
| Equity (Book Value) | 234.60M |
| Book Value Per Share | 6.44 |
| Working Capital | 265.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $166.10 million and capital expenditures -$71.00 million, giving a free cash flow of $95.10 million.
| Operating Cash Flow | 166.10M |
| Capital Expenditures | -71.00M |
| Free Cash Flow | 95.10M |
| FCF Per Share | $2.61 |
Full Cash Flow StatementMargins
Gross margin is 35.16%, with operating and profit margins of 21.01% and -26.20%.
| Gross Margin | 35.16% |
| Operating Margin | 21.01% |
| Pretax Margin | -32.36% |
| Profit Margin | -26.20% |
| EBITDA Margin | 28.50% |
| EBIT Margin | 21.01% |
| FCF Margin | 7.04% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | -0.23% |
| Earnings Yield | -24.02% |
| FCF Yield | 6.46% |
Dividend DetailsAnalyst Forecast
The average price target for Ingevity is $54.33, which is 34.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $54.33 |
| Price Target Difference | 34.48% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 2.19 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.19 |
| Piotroski F-Score | 6 |
